Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment

被引：0

作者：

Thomas, Sarah E. ^{[1
]}

Seyger, Marieke M. B. ^{[1
]}

Mangnus, Josje E. ^{[1
]}

Otero, Marisol E. ^{[1
]}

Gostynski, Antoni H. ^{[2
]}

Njoo, Marcellus D. ^{[3
]}

Ossenkoppele, Paul M. ^{[3
]}

Haeck, Inge M. ^{[4
]}

Hendricksen-Roelofzen, Judith H. J. ^{[5
]}

Koerver, John E. M. ^{[6
]}

Dodemont, Sharon R. P. ^{[7
]}

Tupker, Ron A. ^{[8
]}

Berends, Maartje A. M. ^{[9
]}

Weppner-Parren, Lizelotte M. J. T. ^{[10
]}

Keijsers, Romy R. M. C. ^{[11
]}

Oostveen, Annet M. ^{[12
]}

Peters, Bas ^{[13
]}

Mommers, Roland ^{[14
]}

van Doorn, Martijn B. A. ^{[15
]}

Tjioe, Milan ^{[16
]}

Veldkamp, Wendelien R. ^{[17
]}

Kuijpers, Astrid L. A. ^{[18
]}

Kleinpenning, Marloes M. ^{[19
]}

de Jong, Elke M. G. J. ^{[1
,20
]}

van den Reek, Juul M. P. A. ^{[1
]}

机构：

[1] Radboud Univ Nijmegen, Med Ctr Radboudumc, Dept Dermatol, Mailbox 9101, NL-6500 HB Nijmegen, Netherlands

[2] Maastricht Univ, Dept Dermatol, Med Ctr, Maastricht, Netherlands

[3] Ziekenhuisgroep Twente, Dept Dermatol, Hengelo, Netherlands

[4] Univ Utrecht, Med Ctr, Dept Dermatol, Utrecht, Netherlands

[5] Streekziekenhuis Koningin Beatrix, Dept Dermatol, Winterswijk, Netherlands

[6] Amphia Ziekenhuis, Dept Cardiol, Breda, Netherlands

[7] Catharina Hosp, Dept Dermatol, Eindhoven, Netherlands

[8] St Antonius Hosp, Dept Dermatol, Nieuwegein, Netherlands

[9] Slingeland Ziekenhuis, Dept Dermatol, Doetinchem, Netherlands

[10] Jeroen Bosch Ziekenhuis, Dept Dermatol, sHertogenbosch, Netherlands

[11] Zuyderland Med Ctr, Dept Dermatol, Heerlen, Netherlands

[12] Gelre Ziekenhuizen, Dept Dermatol, Apeldoorn, Netherlands

[13] Ziekenhuis Rijnstate, Dept Dermatol, Arnhem, Netherlands

[14] Anna Ziekenhuis, Dept Dermatol, Geldrop, Netherlands

[15] Erasmus MC, Dept Dermatol, Rotterdam, Netherlands

[16] Bravis Bergen Zoom, Dept Dermatol, Middelburg, Netherlands

[17] Ziekenhuis Gelderse Vallei, Dept Dermatol, Ede, Netherlands

[18] Maxima MC, Dept Dermatol, Eindhoven, Netherlands

[19] Canisius Wilhelmina Ziekenhuis, Dept Dermatol, Nijmegen, Netherlands

[20] Radboud Univ Nijmegen, Nijmegen, Netherlands

来源：

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY | 2024年 / 25卷 / 04期

关键词：

IL-23;

D O I：

10.1007/s40257-024-00868-x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：685 / 688

页数：4

共 50 条

[1] Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis
Koutruba, Nora
Emer, Jason
Lebwohl, Mark
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2010, 6 : 123 - 141
[2] Real-World Experience of Bimekizumab for Plaque Psoriasis in Adult Patients with Prior Exposure to Interleukin-23 Inhibitors: A Multicenter Retrospective Study
Sood, Siddhartha
Rimke, Alexander
Rankin, Brian D.
Abduelmula, Abrahim
Georgakopoulos, Jorge R.
Maliyar, Khalad
Bagit, Ahmed
Leung, Fernejoy
Devani, Alim R.
Vender, Ronald
Yeung, Jensen
Prajapati, Vimal H.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2025, 26 (02) : 301 - 304
[3] Interleukin-23 versus Interleukin-17 Inhibitors in Preventing Incidental Psoriatic Arthritis in Patients with Psoriasis: A Real-World Comparison From the TriNetX US Collaborative Network
Yu, Sebastian
Huo, An-Ping
Wang, Yu-Hsun
Wei, James Cheng-Chung
BIODRUGS, 2025, 39 (02) : 297 - 306
[4] Anti-p40 Antibodies Ustekinumab and Briakinumab: Blockade of Interleukin-12 and Interleukin-23 in the Treatment of Psoriasis
Gandhi, Mona
Alwawi, Eihab
Gordon, Kenneth B.
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2010, 29 (01) : 48 - 52
[5] Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-23 inhibitors: a 52-week multicentre retrospective review
Sood, Siddhartha
Rimke, Alexander
Rankin, Brian
Abduelmula, Abrahim
Georgakopoulos, Jorge
Maliyar, Khalad
Bagit, Ahmed
Leung, Fernejoy
Devani, Alim
Vender, Ronald
Yeung, Jensen
Prajapati, Vimal
BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
[6] Real-World Evidence on Dose Spacing of IL-23 Inhibitors in the Treatment of Psoriasis
Luz, Martim
Torres, Tiago
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2024, 25 (06) : 1019 - 1021
[7] Real-world experience of bimekizumab for plaque psoriasis in adult patients with prior exposure to interleukin-23 inhibitors: a 16-week multicentre retrospective cohort study
Sood, Siddhartha
Rimke, Alexander
Rankin, Brian
Abduelmula, Abrahim
Georgakopoulos, Jorge
Maliyar, Khalad
Bagit, Ahmed
Leung, Fernejoy
Devani, Alim
Vender, Ronald
Yeung, Jensen
Prajapati, Vimal
BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
[8] The utility of interleukin-23 intraclass switching in the treatment of plaque psoriasis: a retrospective review of 43 cases
Hren, M. Grace
Miriyala, Sreekar
Khattri, Saakshi
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, 50 (01) : 137 - 140
[9] Interleukin-23 inhibitors for the treatment of psoriasis in the UK: Early experience of a single secondary care department
Livesey, Amy
Cooper, Hywel
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB103 - AB103
[10] Treatment of psoriasis: janus kinases inhibitors and biologics for the interleukin-23/Th17 axis
Sun, Chunlei
Xia, Jianxin
MINERVA MEDICA, 2020, 111 (03) : 254 - 265

← 1 2 3 4 5 →